Milk Hypersensitivity: Clinical Trials

11 trials for Milk Hypersensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 11
Phase 15Completed 5

Follow Milk Hypersensitivity: new trials by email Literature Review of Milk Hypersensitivity trials Research Report on Milk Hypersensitivity

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults
Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy
Phase 1 / Phase 2CompletedAlladapt Immunotherapeutics, Inc.732021-04-202024-05-16
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
Baked non-fat cow's milk powder, Placebo: Tapioca Powder - Cow's Milk Allergy
Phase 2CompletedJohns Hopkins University412018-03-152025-02-04
Milk Patch for Eosinophilic Esophagitis
Viaskin Milk 500 mcg, Viaskin Placebo - Eosinophilic Esophagitis, Milk Allergy
Phase 2CompletedChildren's Hospital of Philadelphia202015-10-012019-07-10
The Effect of Baked Milk on Cow's Milk Allergy
Baked Milk - Cow's Milk Allergy
Phase 2CompletedHossein Esmaielzadeh1002015-09-012018-04-25
Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy
Viaskin Milk 150 mcg, Viaskin Milk 300 mcg, Viaskin Milk 500 mcg - Food Allergy
Phase 1 / Phase 2CompletedDBV Technologies1982014-11-012024-11-20
Free Amino Acid-based Formula to Treat Children Cow's Milk Protein Allergy
Amix - Cow's Milk Allergy
Phase 2CompletedEdetec Indústria Alimentícia S.A.152013-08-012015-08-31
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
Placebo for omalizumab, Omalizumab, Milk powder - Milk Allergy
Phase 2CompletedHugh A Sampson, MD772010-08-012020-08-14
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
Milk Protein Extract Immunotherapy goal of 4mg/day, Milk Protein Extract Immunotherapy goal of 7mg/day, Milk Powder Immunotherapy goal dose 2000 mg/day - Milk Allergy
Phase 1 / Phase 2CompletedJohns Hopkins University302008-08-012017-05-15
Study of Milk Allergy and Tolerance in Children
Baked Milk, Non-baked Milk - Food Hypersensitivity, Milk Hypersensitivity
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1702008-08-012016-03-30
A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy
cow's milk powder, Placebo - Milk Hypersensitivity
Phase 1 / Phase 2CompletedJohns Hopkins University202006-08-012017-04-20
Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques).
Procedure - Milk Allergy
Phase 1 / Phase 2CompletedNambudripad's Allergy Research Foundation262005-01-012006-05-22

Narrower conditions

Food Hypersensitivity (7)  ·  Hypersensitivity (2)  ·  Egg Hypersensitivity (1)  ·  Eosinophilic Esophagitis (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Nut Hypersensitivity (1)  ·  Peanut Hypersensitivity (1)  ·  Shellfish Hypersensitivity (1)  ·  Wheat Hypersensitivity (1)

Broader conditions

Hypersensitivity, Immediate (10)  ·  Immune System Diseases (10)  ·  Hypersensitivity (9)  ·  Food Hypersensitivity (4)  ·  Digestive System Diseases (1)  ·  Eosinophilia (1)  ·  Esophageal Diseases (1)  ·  Esophagitis (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukocyte Disorders (1)  ·  Nut and Peanut Hypersensitivity (1)

Interventions

Drugs, Investigational (1)  ·  Methods (1)  ·  Omalizumab (1)  ·  Refit milk powder (1)

Sponsors

Johns Hopkins University (3)  ·  Alladapt Immunotherapeutics, Inc. (1)  ·  Children's Hospital of Philadelphia (1)  ·  DBV Technologies (1)  ·  Edetec Indústria Alimentícia S.A. (1)  ·  Hossein Esmaielzadeh (1)  ·  Hugh A Sampson, MD (1)  ·  Nambudripad's Allergy Research Foundation (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (9)  ·  Canada (1)  ·  Iran (1)

Top investigators

Robert Wood, MD (2)  ·  Anna Nowak-Wegrzyn, MD (1)  ·  Antonella Cianferoni, MD, PhD (1)  ·  Devi S Nambudripad, DC,PhD,L.Ac (1)  ·  Hossein Esmaeilzadeh (1)  ·  Hugh A. Sampson, M.D. (1)  ·  Hugh A. Sampson, MD (1)  ·  Mei-Lun Wang, MD (1)  ·  Robert A Wood, MD (1)  ·  Wendel O Afonso, Master (1)

Results publications

PMID 18951617, PMID 25609353, PMID 26581915, PMID 30027590, PMID 31100455, PMID 33006765, PMID 38407859, PMID 39782691

NIH funding

U19AI044236 (1)